posted
Avitar Aims to Increase Its Share of $1.5B Diagnostic Market
CANTON, Mass., Dec 03, 2007 (BUSINESS WIRE) -- Avitar Inc. ("AVTI") (OTCBB:AVTI), manufacturers of nationally branded oral fluid testing diagnostic devices and customized polyurethane applications used in wound dressings, announced today that, because of a recent GAO study of the Department of Transportation urine-based testing procedures and their high rate of failures, the patented Avitar ORALscreen(R) technology will quickly gain favor. Drug abuse remains a major problem in the transportation sector, as well as construction, manufacturing, hospitality, and retail, due to the limitations associated with urine-based drug testing. Peter Phildius, Avitar's Chairman and CEO, discussed the GAO study. "We believe that the door is now open wide for us to capture a large segment of the estimated $1.5B drug testing market. We are already selling to several cross-sector industry leaders, (Best Buy, Del Monte, Hilton, Sheraton and ADM), as well as small- to mid-sized companies that are receiving multiple benefits, such as lower employee turnover, higher quality workforce, and reductions of up to 50% in their accident rates. There is no competitive product to our ORALscreen(R) instant on-site testing device which detects prescription pain relievers such as Oxycontin(R) and Percoset(R), as well as other commonly abused substances in 15 minutes or less."
Being relatively unknown for the past six years, the Company looks to 2008 as a banner year for rapid expansion into all segments of the drug testing market. The Company has hired a PR firm to begin "telling our story", elevating investor awareness and shareholder value.
About Avitar, Inc.
Avitar Inc. develops, manufactures and markets innovative proprietary products. Markets include fluid diagnostics, disease and clinical testing, and customized applications for wound dressings. Principal products include ORALscreen(R), (the first non-invasive, rapid, onsite oral fluid test for drugs-of-abuse), and Hydrasorb(R), (an absorbent topical dressing for moderate to heavy exudating wounds). Avitar is also developing diagnostic strategies for disease and clinical testing in the estimated $25 billion in-vitro diagnostics market. Conditions targeted include influenza, diabetes, and pregnancy. For more information, see Avitar's website at http://www.avitarinc.com.
Avitar Inc. is a fully reporting company whose stock trades on the OTCBB under the symbol "AVTI.OB". For information, contact Investor Relations 781-821-2440 - Peter Cholakis, VP - Marketing.
Forward-Looking Statements
This release contains forward-looking statements that are subject to risks and uncertainties including the development and marketing of new applications and other risks that are detailed from time to time in the Company's filings with the Securities and Exchange Commission. In view of such risks and uncertainties, the Company's actual results could differ materially from those anticipated in such forward-looking statements.
Disclosure Category Current Information Primary SIC — Industry Classification 8082 - Home health care services State Of Incorporation DE Jurisdiction Of Incorporation USA Company Officers Peter P. Phildius, CEO Jay Leatherman, CFO
SEC Reporting Status SEC Reporting Company CIK 0000814008 Fiscal Year End 9/30 Estimated Market Cap 182,488.536 as of Nov 30, 2007 Outstanding Shares 45,622,134 as of Aug 10, 2007 Number of Share Holders of Record 350 as of Jan 25, 2006 Current Capital Change shs decreased by 1 for 50 split Pay Date: Feb 21, 2006 Company Notes Formerly=Managed Health Benefits Corp. until 5-95 Security Notes Note=8-29-05 deleted from AMEX New Issue=6-87 750,000 shs at $2 (best efforts-400,000 min.) by Jerold Securities & Co., Inc. Transfer Agent Continental Stock Transfer & Trust Company, 17 Battery Place 8th Floor New York, NY 10004
-------------------- LIFE IS 10% HOW YOU MAKE IT AND 90% HOW YOU TAKE IT!
IP: Logged |
posted
Dec 4, 2007 *********.com: Speak with other shareholders about: (OTCBB: AVTI), (NASDAQ: XMSR), (OTCBB: THPW), (Nasdaq: XLNX), (OTCBB: SPNG). Dec 4, 2007 *************: Early Market Standouts List for December 4, 2007: RHGP Wins Bid for Prime Time Advertising on CCTV During the Olympics! Dec 4, 2007 RealPennies.com: RealPennies.com: Turning Pennies into dollars: (OTCBB:AVTI), (OTCBB: CRGO),(OTCBB: TCCO),(OTCBB: LBAS) Dec 4, 2007 RealPennies.com: RealPennies.com: Turning Pennies into dollars: (Pink Sheets: PSMH), (OTCBB: BUGS), (OTCBB: AVTI), (OTCBB: MICG). Dec 4, 2007 BeaconEquityResearch.com: Beacon Equity Research reports on the OTC and OTCBB Trade Leaders: Campbell Resources Inc. (OTCBB: CBLRF), Avitar Inc. (OTCBB: AVTI), Interactive Motorsports and Entertainment Corporation (OTCBB: IMTS), Ceragenix Pharmaceuticals, Inc. (OTCB: CGXP), and China Organic... PUMP IT UP!!!!!
-------------------- LIFE IS 10% HOW YOU MAKE IT AND 90% HOW YOU TAKE IT!
IP: Logged |